DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells - PubMed (original) (raw)
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells
Mattias Carlsten et al. Cancer Res. 2007.
Abstract
Although natural killer (NK) cells are well known for their ability to kill tumors, few studies have addressed the interactions between resting (nonactivated) NK cells and freshly isolated human tumors. Here, we show that human leukocyte antigen class I(low) tumor cells isolated directly from patients with advanced ovarian carcinoma trigger degranulation by resting allogeneic NK cells. This was paralleled by induction of granzyme B and caspase-6 activities in the tumor cells and significant tumor cell lysis. Ovarian carcinoma cells displayed ubiquitous expression of the DNAX accessory molecule-1 (DNAM-1) ligand PVR and sparse/heterogeneous expression of the NKG2D ligands MICA/MICB and ULBP1, ULBP2, and ULBP3. In line with the NK receptor ligand expression profiles, antibody-mediated blockade of activating receptor pathways revealed a dominant role for DNAM-1 and a complementary contribution of NKG2D signaling in tumor cell recognition. These results show that resting NK cells are capable of directly recognizing freshly isolated human tumor cells and identify ovarian carcinoma as a potential target for adoptive NK cell-based immunotherapy.
Similar articles
- Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, Steinle A, Salih HR. Armeanu S, et al. Cancer Res. 2005 Jul 15;65(14):6321-9. doi: 10.1158/0008-5472.CAN-04-4252. Cancer Res. 2005. PMID: 16024634 - NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
Verhoeven DH, de Hooge AS, Mooiman EC, Santos SJ, ten Dam MM, Gelderblom H, Melief CJ, Hogendoorn PC, Egeler RM, van Tol MJ, Schilham MW, Lankester AC. Verhoeven DH, et al. Mol Immunol. 2008 Sep;45(15):3917-25. doi: 10.1016/j.molimm.2008.06.016. Epub 2008 Jul 26. Mol Immunol. 2008. PMID: 18657862 - The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
El-Sherbiny YM, Meade JL, Holmes TD, McGonagle D, Mackie SL, Morgan AW, Cook G, Feyler S, Richards SJ, Davies FE, Morgan GJ, Cook GP. El-Sherbiny YM, et al. Cancer Res. 2007 Sep 15;67(18):8444-9. doi: 10.1158/0008-5472.CAN-06-4230. Cancer Res. 2007. PMID: 17875681 - NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions.
Morgado S, Sanchez-Correa B, Casado JG, Duran E, Gayoso I, Labella F, Solana R, Tarazona R. Morgado S, et al. J Innate Immun. 2011;3(4):365-73. doi: 10.1159/000328505. Epub 2011 May 11. J Innate Immun. 2011. PMID: 21576932 Review. - The NKG2D receptor: sensing stressed cells.
López-Larrea C, Suárez-Alvarez B, López-Soto A, López-Vázquez A, Gonzalez S. López-Larrea C, et al. Trends Mol Med. 2008 Apr;14(4):179-89. doi: 10.1016/j.molmed.2008.02.004. Epub 2008 Mar 18. Trends Mol Med. 2008. PMID: 18353724 Review.
Cited by
- Construction of a prognostic model for ovarian cancer based on a comprehensive bioinformatics analysis of cuproptosis-associated long non-coding RNA signatures.
Chen R, Huang Y, Sun K, Dong F, Wang X, Guan J, Yang L, Fei H. Chen R, et al. Heliyon. 2024 Jul 23;10(15):e35004. doi: 10.1016/j.heliyon.2024.e35004. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170367 Free PMC article. - The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy.
Murakami K, Ganguly S. Murakami K, et al. Front Immunol. 2024 Aug 2;15:1441730. doi: 10.3389/fimmu.2024.1441730. eCollection 2024. Front Immunol. 2024. PMID: 39156900 Free PMC article. Review. - Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME).
Sadeghi M, Dehnavi S, Sharifat M, Amiri AM, Khodadadi A. Sadeghi M, et al. Heliyon. 2024 Mar 3;10(5):e27480. doi: 10.1016/j.heliyon.2024.e27480. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38463798 Free PMC article. Review. - Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment.
Paolini R, Molfetta R. Paolini R, et al. Cancers (Basel). 2023 Sep 18;15(18):4616. doi: 10.3390/cancers15184616. Cancers (Basel). 2023. PMID: 37760586 Free PMC article. Review. - CD155 and Its Receptors as Targets for Cancer Therapy.
Paolini R, Molfetta R. Paolini R, et al. Int J Mol Sci. 2023 Aug 19;24(16):12958. doi: 10.3390/ijms241612958. Int J Mol Sci. 2023. PMID: 37629138 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials